From Concept to Medicine - A Comprehensive Drug Development Journey

Nearly 45% of all deaths from non-communicable diseases worldwide are caused by cardiovascular disease—a staggering reality that frames the story of atorvastatin, better known as Lipitor. In this episode of From Concept to Medicine’s Periodic Table of Medicine , we trace the full journey of one of the world’s most influential drugs. From the centuries-long unraveling of cholesterol’s chemistry, th...

In this compelling Deep Dive, we explore the unglamorous but absolutely essential world of medical device documentation. From design inception to post-market surveillance, documentation isn't just red tape—it's the backbone of compliance, traceability, and patient safety. This episode introduces listeners to the U.S. FDA's regulatory foundation in 21 CFR Part 820 and shines a spotlight on ALCOA+ p...

In this expansive episode of The Deep Dive , we explore the full lifecycle of liraglutide , a first-generation GLP-1 receptor agonist that helped redefine how we treat both type 2 diabetes and obesity. From the early 20th-century discovery of incretin hormones to the molecular engineering breakthroughs that enabled liraglutide’s once-daily dosing, the episode traces the drug’s scientific and clini...

In this compelling episode of The Deep Dive , we explore the multifaceted story of pioglitazone , a thiazolidinedione (TZD) insulin sensitizer used to treat type 2 diabetes. From its origins in 1980s Japan to its development as a follow-up to troglitazone—the first but short-lived TZD—we trace how pioglitazone emerged as a promising therapy that targets insulin resistance at the genetic level thro...

In this episode of The Deep Dive , we explore the full lifecycle of sitagliptin , the first oral DPP-4 inhibitor to revolutionize type 2 diabetes management. Starting with its scientific origins in the 1990s, the episode traces how researchers discovered the role of incretin hormones and developed sitagliptin to preserve their glucose-lowering effects. Listeners will learn how sitagliptin works se...

In this episode of The Deep Dive , we explore the remarkable journey of exenatide , a diabetes medication that began in an unlikely place— Gila monster saliva . As the first GLP-1 receptor agonist approved for type 2 diabetes, exenatide paved the way for an entirely new class of blood sugar–lowering treatments. We trace its evolution from the twice-daily Byetta to the once-weekly Bydureon , highli...

In this in-depth episode of From Concept to Medicine , we take a comprehensive look at glipizide , a widely used second-generation sulfonylurea for type 2 diabetes. The episode begins with a historical overview of the sulfonylurea class and glipizide’s role in the evolution of diabetes care, comparing it to older drugs like tolbutamide and glyburide. We explore how glipizide functions—stimulating...

In this deep dive, we explore the foundation of U.S. medical device quality regulation: the FDA’s Quality System Regulation, also known as 21 CFR Part 820. Framed as more than just paperwork, the QSR is revealed to be the operational heartbeat of device manufacturing, akin to a Michelin-starred kitchen where quality, safety, and consistency are designed into every step. From the first design sketc...

This episode explores the FDA’s regulatory pathways for medical device clearance and approval, peeling back the layers of risk-based classification and submission strategies. From simple class I devices like elastic bandages to high-stakes class III implants, the discussion walks listeners through how the FDA applies escalating levels of scrutiny depending on patient risk. The episode introduces e...

In this comprehensive deep dive, we journey through the entire lifecycle of a medical device—from that first spark of an idea to post-market surveillance. The episode unpacks the structured and often invisible process that transforms innovation into real-world solutions. Starting with conceptualization and design input, the hosts guide listeners through risk management, design controls, verificati...

In this epic exploration, we trace the astonishing story of insulin , a life-saving hormone that reshaped modern medicine—and human destiny. From its biological roots in ancient evolutionary systems (even cone snails use insulin-like molecules as venom!) to its discovery by Banting and Best in the 1920s, this episode unveils insulin’s complex journey through science and society. We unpack how this...

In this sweeping exploration of Metformin, we uncover the remarkable transformation of a medieval herbal remedy into one of the world’s most essential medicines for managing type 2 diabetes. Originating from Galega officinalis —also known as goat’s rue—this botanical curiosity led scientists on a century-long quest, culminating in the rediscovery of Metformin after earlier biguanides proved too to...

Clindamycin may not be the flashiest antibiotic on the shelf, but its journey from a chlorinated cousin of lincomycin to a crucial treatment for bone infections, surgical prophylaxis, and penicillin-allergic patients tells a powerful story of medical utility and regulatory evolution. In this Deep Dive, we trace its origins back to 1970s FDA approvals and follow its regulatory path through updated...

In this Deep Dive, we unravel the intricate story of Levofloxacin , a third-generation fluoroquinolone antibiotic with a sweeping medical profile and a regulatory history to match. Originally patented in 1987 and approved by the FDA in 1996, Levofloxacin quickly became a go-to option for serious bacterial infections like pneumonia, prostatitis, skin infections, and even life-threatening threats li...

Ciprofloxacin—once hailed as a miracle of modern medicine—takes center stage in this expansive episode of The Deep Dive . We trace its journey from its roots in the quinolone family to its transformation into a potent fluoroquinolone following a key molecular tweak: a single fluorine atom. Developed by Bayer and launched in 1987, Cipro rapidly became a staple in the fight against infections rangin...

In this foundational episode, we explore how medical devices are defined and classified by the FDA—a critical first step in navigating the regulatory landscape. Starting with the legal distinction between devices and drugs, we unpack the FDA’s risk-based classification system that categorizes devices into Class I, II, or III based on their potential harm to patients. The discussion delves into how...

Azithromycin may be the most recognizable “Z-Pak” in the pharmacy, but its journey from Eastern European innovation to global blockbuster is anything but ordinary. This episode follows its origins as a chemical upgrade to erythromycin, engineered for better stability, longer half-life, and deeper tissue penetration. That dual-action—antibacterial and immunomodulatory—helped it conquer a wide array...

Erythromycin has been punching above its weight for decades. In this episode, we chart its rise from a soil-derived discovery by Saccharopolyspora erythraea to its position as a foundational macrolide antibiotic. Known for jamming the protein production machinery in bacteria, erythromycin treats everything from strep throat and pneumonia to neonatal eye infections and even gastroparesis. Its abili...

Amoxicillin is everywhere—from pediatricians’ offices to disaster relief kits—and for good reason. In this episode, we dive into its 1970s debut as a more bioavailable cousin to ampicillin, crafted by Beecham Laboratories. We unpack its role as a semi-synthetic penicillin, its mechanism of action as a beta-lactam antibiotic, and why its oral absorption made it a clinical favorite. Whether it’s tac...

Few drugs have reshaped the world like penicillin. In this episode, we trace its origin story—from Alexander Fleming’s serendipitous discovery in 1928 to the urgent push during World War II that turned moldy lab dishes into mass-produced medicine. We spotlight the critical roles of Florey, Chain, and Heatley, whose tireless work at Oxford transformed penicillin into a viable therapeutic agent. Wit...

In this episode of From Concept to Medicine , we dive into the story of Celecoxib , the first blockbuster COX-2 selective NSAID, widely known by its brand name Celebrex . Designed to relieve pain and inflammation with fewer gastrointestinal side effects than traditional NSAIDs, Celecoxib emerged from decades of pharmaceutical research seeking the elusive “safer NSAID.” We explore how it fits into...

In this episode of The Deep Dive , we explore the complex and often surprising story of Diclofenac , a pain reliever that’s as powerful as it is controversial. From its origins in the labs of Ciba-Geigy in the late 1960s to its widespread use today in pills, gels, patches, and even eye drops, Diclofenac has become a global staple in pain management. But what sets it apart isn’t just its therapeuti...

In this illuminating episode of The Deep Dive , we trace the remarkable journey of Naproxen—from its surprising roots in steroid chemistry using Mexican yams to its rise as one of the most familiar over-the-counter pain relievers on the market. We explore how Syntex, a pioneer in hormone synthesis, pivoted to pain relief innovation in the late 1960s, and how that pivot led to the development of a...

In this episode, we dive deep into ibuprofen, one of the most widely used non-steroidal anti-inflammatory drugs (NSAIDs) in the world. From its discovery in the 1960s to its current status as a household name, we explore the fascinating journey of this versatile medication. We'll examine its unique mechanism of action, comparing it to aspirin and other pain relievers, while discussing its role in...

Join us as we explore acetaminophen, one of the most widely used pain relievers in the world. We'll dive into the fascinating journey of how this medication evolved from its discovery to becoming a household name as Tylenol. Through engaging discussions and real-world examples, we'll examine its mechanism of action, proper usage guidelines, and why it has become the go-to choice for fever and pain...